PAVmed Inc. Stockholders Equity

Quick Answer

PAVmed Inc. reported Stockholders Equity of $33.97 million for fiscal year 2025.

PAVmed Inc. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $33.97M +1461.4%
2024 -$2.50M +95.4%
2023 -$53.83M -456.0%
2022 -$9.68M -115.7%
2021 $61.67M +3152.4%
2020 $1.90M +149.6%
2019 -$3.82M -65.2%
2018 -$2.31M +18.7%
2017 -$2.85M -792.7%
2016 -$319.1K -150.3%
2015 $633.9K -20.2%
2014 $794.8K

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $32.52M +767.9% -13.3%
June 30, 2025 $37.53M +150.8% -16.6%
March 31, 2025 $44.99M +165.4% +1699.8%
January 31, 2025 $2.50M +200.2%
December 31, 2024 -$2.50M +95.4% +48.8%
September 30, 2024 -$4.87M +88.7% +93.4%
June 30, 2024 -$73.94M -134.7% -7.5%
March 31, 2024 -$68.78M -211.8% -27.8%
  • PAVmed Inc. showed an increase of +1461.4% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2014–2025 period, PAVmed Inc.’s stockholders equity has grown by 4173.5% (from $794.8 thousand to $33.97 million).
  • The most recent figure is from PAVmed Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment